ARTICLE | Company News
Maxygen, Roche deal
May 15, 2006 7:00 AM UTC
MAXY received a $5 million milestone payment from ROCZ under their December 2005 deal to develop and commercialize preclinical recombinant Factor VIIa proteins for acute bleeding indications (see Bio...